Buffett had never demonstrated interest in pharmaceutical companies before, but he had four new pharmaceutical companies in his portfolio, including: 21,264,316 shares of AbbVie valued at $1.86 billion. 22,403,102 shares of Merck valued at $1.86 billion. 29,971,194 shares of Bristol Myers Squibb valued at $1.81 billion. More items...